Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Prepaid Assets: 2017-2024

Historic Prepaid Assets for Cidara Therapeutics (CDTX) over the last 8 years, with Dec 2024 value amounting to $12.9 million.

  • Cidara Therapeutics' Prepaid Assets fell 47.26% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year decrease of 47.26%. This contributed to the annual value of $12.9 million for FY2024, which is 651.52% up from last year.
  • Per Cidara Therapeutics' latest filing, its Prepaid Assets stood at $12.9 million for FY2024, which was up 651.52% from $1.7 million recorded in FY2023.
  • Over the past 5 years, Cidara Therapeutics' Prepaid Assets peaked at $12.9 million during FY2024, and registered a low of $1.7 million during FY2023.
  • In the last 3 years, Cidara Therapeutics' Prepaid Assets had a median value of $6.5 million in 2022 and averaged $7.0 million.
  • As far as peak fluctuations go, Cidara Therapeutics' Prepaid Assets plummeted by 73.78% in 2023, and later surged by 651.52% in 2024.
  • Over the past 5 years, Cidara Therapeutics' Prepaid Assets (Yearly) stood at $3.1 million in 2020, then skyrocketed by 32.67% to $4.1 million in 2021, then skyrocketed by 60.48% to $6.5 million in 2022, then plummeted by 73.78% to $1.7 million in 2023, then skyrocketed by 651.52% to $12.9 million in 2024.